1 Strips of rabbit blood vessels were suspended in vitro and responses to complement peptides C3a and C5a were recorded isotonically.
Introduction
When complement is activated in animal sera it . A serum carboxypeptidase becomes broncoconstrictive and vasoactive (see Bor- removes the C-terminal arginine residue from anadet, 1913; Hicks & Sackeyfio, 1972) . Complex phylatoxins C3a, C4a and C5a when generated in vivo; cardiovascular responses to a peptide purified from but only the C5a molecule retains significant activity complement-activated hog serum were reported in the in the des-Arg form.
guinea-pig (Bodamer & Vogt, 1967) and in the dog Porcine C5ade,Arg is a hypotensive peptide both in (Pavek et al., 1979) . That this peptide is the 'classical the guinea-pig and in the dog. A reversible hypotensive anaphylatoxin' C5adesArg is now well established phase followed by a tachyphylactic, catecholaminedependent hypertensive phase was observed in the 'To whom correspondence should be sent guinea-pig after intravenous injection of classical ©The Macmillan Press Ltd 1985 anaphylatoxin (Bodamer & Vogt, 1967; Hicks & Sackeyfio, 1972) . In the dog, CSadesArg reduced systemic arterial blood pressure but caused pulmonary hypertension (Pavek et al., 1979) . Indomethacin prevented the C5ade,sArg-dependent hypotension in the dog, suggesting that cyclo-oxygenase products mediate this cardiovascular effect of the anaphylatoxin.
The perfusion pressure of the guinea-pig lung was variably increased by C5adesArg (Pavek et al., 1979) . Regal (1982) and Marceau & Hugli, (1984) have described a vasoconstrictor effect of CSa on guineapig isolated blood vessels. Vasoconstriction was apparently mediated by a combined effect of histamine and cyclo-oxygenase products. Furthermore, histamine and prostaglandins, but no slow reacting substance ofanaphylaxis (SRS-A) activity, were detected by bioassay in the effluent of C5a-perfused lung tissue (Pavek et al., 1979) .
The present investigation was undertaken to characterize further the vascular effects of purified anaphylatoxin C5a in its fully active form, and eventually, describe an in vitro model for CSa-induced vascular relaxation related to its hypotensive effect in vivo.
Methods

Isolated blood vessels
New Zealand white rabbits (1.5 -3 kg) were killed by stunning and exsanguination. Segments of blood vessels were removed, prepared and cut helically as described by Marceau & Hugli (1984) . Three adjacent strips were generally obtained from each vessel segment and each strip was treated randomly with one of the three concentrations of CSa. The vascular strips were at least 8 mm long and 2 mm wide and were suspended in 2.5 ml organ bath containing oxygenated (95% 02 and 5% C02) and warmed (37C) Krebs solution. The composition of Krebs solution and the procedure for recording isotonic contractions were described previously (Marceau & Hugli, 1984) .
Protocols
The vascular strips were equilibrated for 45 min under a resting tension of 0.5 g. Most of the observations were performed on portal vein and pulmonary artery strips constricted with noradrenaline (NA). A moderate concentration (ED30-ED40) of NA (200 nM) was used to generate tone, so that vasodilator effects could be recorded, in a similar manner to Gagnon et al. (1978) and Forstermann et al. (1984) . After NA application, a contraction plateau was reached and C5a was then applied. Changes elicited by C5a were expressed as either a positive (e.g. further enhancement of contraction) or negative (e.g. a relaxation) percentage of the NA-induced contraction. Typically, C5a produced a brief contraction followed by a relaxation of the rabbit portal vein and a relaxation of the pulmonary artery without a contraction phase. After the effect of C5a had worn off, tissues were washed and allowed to recover for 45 min, after which the procedure was repeated. Each tissue was exposed initially to NA, and then to NA and C5a for three successive applications as a means of assessing changes in the C5a effect during in vitro incubation. The first and third exposure to C5a typically occurred 1.5 and 4h respectively from the start of the in vitro incubation.
In experiments with inhibitory drugs, the tissues were exposed to a constant concentration of the drug throughout the experiment.
Radioimmunoassays (RIA)
To monitor the influence of CSa on arachidonate metabolism in vascular strips the bathing Krebs fluid was sampled at various times and submitted to a RIA for 6-keto-prostaglandin F,, (6-keto-PGF1,) and thromboxane B2 (TXB2). The 3H-RIA kits for these two compounds were purchased from New England Nuclear, Boston, MA. The samples (100 il) were usually applied directly without extraction. Ether-extracted samples reconstituted in saline yielded quanitatively similar results to unextracted samples, suggesting that the immunoreactive substances were indeed lipids. Krebs solution was added to the samples of 6-keto-PGFI,, and TXB2 used to construct standard curves, as suggested by the manufacturer of the kits, in order to compensate for solvent effects on the assays. Major crossreacting prostaglandins were PGE2 (2.5%) for the 6-keto-PGF1, assay and PGD2 (2.0%) for the TXB2 assay. Results are expressed in nM concentrations in the original bathing fluid. (Weichman et al., 1984a,b) , was a generous gift of Smith, Kline and French, Philadelphia, PA, U.S.A.
Solutions of the drugs (0.1-1 mg ml'-) were made in 0.9% saline and small volumes (1 -20 1l) were injected into the tissue bath at the appropriate times. Indomethacin was dissolved in I M NaHCO3 and SKF 88046 in 0.1 M Na2CO3.
Anaphylatoxin C5a preparation
Human anaphylatoxin C5a was used throughout the present studies and was prepared according to . C5a was homogeneous material as judged by cellulose acetate electrophoresis. Some experiments were performed using material obtained from the trailing end of the C5a peak eluted from CM Sephadex, as described by Fernandez & Hugli (1976) . In the latter case, the C5a concentration was determined by bioassay (guinea-pig ileum) and this material produced the same response as homogeneous C5a on vascular strips prepared from guinea-pigs or rabbits. Homogeneous human C3a was also used in some experiments .
Results
Effect ofC5a on rabbit isolated blood vessels
Human C5a (up to 59 nM) exhibited minimal effects on resting rabbit blood vessels as measured by contraction. No contractile response to C5a was detected on the thoracic aorta or the pulmonary artery, tissues that exhibit neither resting tone nor spontaneous activity. However, the spontaneous activity of the portal vein was decreased by C5a (Figure la) and this response could be elicited repeatedly on the same strip. Relaxation of the portal vein was sometimes preceded by a small contraction. If the portal vein was first constricted with NA (200 nM), it generally exhibited a biphasic response to C5a at 2.9, 15 or 59 nM levels (Figure lb, statistical analysis in Figure 2 ). A C5a-induced contraction exceeding the NA plateau was initially apparent and this effect was not strictly dosedependent ( Figure 2 ). The contractile effect was tachyphylactic since it decreased with subsequent applications of C5a. This contractile phase was highly variable and lacking in some animals. The second phase of the response was a relaxation of the tissue. Relaxation developed more slowly, was reversible, dose-dependent, and increased considerably in magnitude with subsequent applications of the same concentration of C5a (e.g. it doubled approximately from the first to the third application at 2.9 nM, see Figure 2 ). Maximal relaxation obtained on the portal vein averaged 44% after the third application of C5a using the highest concentration of 59 mM.
The response of NA-constricted pulmonary artery to C5a was generally a monophasic reversible relaxation ( Figure I c, Figure 2 ). Relative to the NA plateau, relaxation of the pulmonary artery was less marked than that of the portal vein; however, it was still dosedependent and increased with subsequent applications of C5a. The rabbit thoracic aorta responded minimally to C5a (Figure 2) .
In contrast to the C3a effect on guinea-pig blood vessels (Marceau & Hugli, 1984) became similar to the third response of the control tissues. That is, the early contractile phase was reduced and the late relaxation was increased after the first exposure. These trends were statistically significant at the 2.9 nM level of C5a (contractile phase reduced to 7.1 ± 3.2%, P<0.05 and relaxation increased to 24.1 ± 4.7%, P < 0.02, n = 5).
Radioimmunoassay of cyclo-oxygenase products
In order to monitor the effects of C5a on arachidonate metabolism, vascular strips were exposed to C5a and aliquots of the bathing fluid were taken for analysis of 6-keto-PGFI. and TXB2. F6rstermann et al. (1984) examined patterns of prostaglandin release from rab- Control M M + I Figure 4 Effect of mepyramine, indomethacin or a combination of both on C5a-induced responses of the rabbit isolated pulmonary artery. Concentration of drugs, abbreviations and group sizes are the same as in Figure 3 . (a) Pulmonary arteries challenged with 2.9 nM C5a. (b) Pulmonary arteries challenged with 59 nM C5a. Each phase of the response has been compared to controls using Student's t test (* P <0.05 and **P <0.01). bit blood vessels. It appears that prostacyclin (PGI2) is the predominant cyclo-oxygenase product released, followed by PGE2, and that the ratio between these different products is maintained both during basal release conditions and after stimulation (e.g. with exogenous arachidonic acid). The present analysis has been limited to decay products of two active and physiologically antagonistic cyclo-oxygenase products, PGI2 and TXA2. It can beseen from Table 1 that vascular strips excised from animals assigned to this study gave typical responses to C5a.
There is a measurable basal release of PGI2 from both rabbit portal vein and pulmonary artery tissue as judged by 6-keto-PGF1, concentrations in the bathing fluid (Table 2 ). Ten minutes after washing fresh tissue, 6-keto-PGF1, increased from undetectable levels (<0.27 nM) to 1.85-2.11 nM from portal vein and 0.67-1.03 nM from the pulmonary artery. Addition of NA (2 x 10-7 M) caused a moderate increase of 6-keto-PGFi, concentrations in the bathing fluid at approxitely 3 min after application. Vasoconstrictors such as NA and angiotensin II are known to be moderate stimulators of cyclo-oxygenase products from vascular strips (Forstermann et al., 1984) . The tissues were then challenged with C5a (59 nM) and 6-keto-PGFI, levels were measured after development of the biological response. Total levels of 6-keto-PGF1, increased considerably (up to 6.10nM on the portal vein) after C5a stimulation. C5a also induced a measurable increase in the TXB2 concentration in most cases (up to 0.24nM). Changes in TXB2 levels were considerably less than those for 6-keto-PGF1, and basal release levels ofTXB2 were usually below the limits of detection (< 0.14 nM). Prostanoid output was generally less pronounced from pulmonary artery strips than from portal veins on a wet weight basis. Injection of C5a on nonconstricted (i.e. NA-free) vascular strips also increased the concentration of 6-keto-PGF,1 and TXB2 in the supernatant; this suggests that NA is not involved in C5a-stimulated release of PG12 and TXA2.
Both basal and stimulated release of 6-keto-PGF,1 and TXB2 generally decreased in rate after 3.5 h of incubation; this period included a second challenge by C5a. Results after a third exposure to NA and C5a are given in Table 2 .
Indomethacin (5.6[iM) inhibited by 83% or more the release of immunoreactive 6-keto-PGF1, from freshly isolated rabbit portal veins; TXB2 release was undetectable under these conditions.
Discussion
The present data suggest that the active fragment C5a of the complement system can stimulate vasomotor mechanisms. C5a elicited contractile responses in certain isolated blood vessels from the guinea-pig (Regal, 1982; Marceau & Hugli, 1984) ; conversely a relaxant response was observed on rabbit vascular strips. Despite opposing mechanical effects of C5a on vessels excised from these two species, similarities in response were observed for tissues taken from both animals. The C5a response in both species involved primarily cyclo-oxygenase products with a minor contribution by histamine. In the rabbit portal vein, histamine partially mediated the initial transient contractile phase elicited by C5a. Organ responsiveness was the same in both rabbits and guinea-pigs; the portal vein was consistently the most responsive of the blood vessels sampled while the pulmonary artery and the aorta were less reactive. One surprising observation was the lack of an effect of human C3a on rabbit vascular strips because guinea-pig blood vessels have been shown previously to be contracted by human C3a (Marceau & Hugli, 1984 (Marceau & Hugli, unpublished results) . This high ratio of TXA2 to PGI2, in combination with histamine release, could account for the contractile effect of C5a in this species. Nevertheless, PG!2 was released by C5a from guinea-pig vascular tissues and this release might be significant in certain vascular beds because the classical anaphylatoxin is known to be hypotensive in the anaesthetized guineapig (Bodamer & Vogt, 1967 (Weichman et al., 1984a,b) , apparently inhibited the contractile phase and uncovered the full relaxation effect of C5a at its first application. However, SKF 88046 did not potentiate relaxation of the pulmonary artery and evidence derived from its utilization will be oflimited value until its activity against various prostanoids is better elucidated in vascular systems.
C5a stimulates the release of low-molecular weight agents, especially histamine and various arachidonic acid metabolites. These secondary mediators, in variable proportions, seem to account entirely for the action of C5a on various smooth muscle preparations from the guinea-pig. The influence of C5a has been characterized on vascular tissues (Regal 1982; Marceau & Hugli, 1984) , tracheal and pulmonary strips (Regal & Pickering 1981; Stimler et al., 1981; 1982) and the ileum (Cochrane & Muller-Eberhard, 1968 ). The present data on rabbit blood vessels further support the lack of a direct effect of C5a on smooth muscle. The cell types responsible for production of cyclo-oxygenase products remain to be identified although endothelial cells are the major cellular source of PGI2 and are also a significant source of TXA2 in some species (Higgs & Moncada, 1983) . Therefore, it will be interesting to investigate whether these cells possess receptors for C5a or are indirect targets for mediators released from tissues by C5a.
It is tempting to speculate that intravascular activation of complement can lead to prostaglandinmediated vasodilatation in some organs and contribute to inflammatory changes. Vasodilator prostaglandins, such as PGE2 and PGI2, are suspected of increasing blood flow in inflamed areas and contributing to exudate formation in conjunction with other factors active on vascular permeability (Wedmore & Williams, 1981; Williams & Morley, 1973) . In addition to the present data, Rampart et al. (1983) showed that tryptic fragment of human C5, behaving like C5a on gel filtration, could release PGI2 from rabbit mesentery pieces. Thus, C5a could be an important link between complement activation and the inflammatory vascular event.
